-+ 0.00%
-+ 0.00%
-+ 0.00%

COMPASS THERAPEUTICS INC. : LEERINK PARTNERS ASSUMES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $4

Reuters·07/22/2026 04:03:17

Please log in to view news